INS and Hyperglycemia: Using the HFD + higher STZ dose, we report the induction of hyperglycaemia, impaired glucose tolerance, hyperlipidaemia and continued decline in beta cell insulin‐production, which are hallmarks of established type 2 diabetes where patients are typically diagnosed.